Results 91 to 100 of about 22,236,668 (323)
Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab.
BACKGROUND Immune-related adverse events (irAEs) are known to occur in patients with cancer who are treated with immune checkpoint inhibitors. However, limited literature exists on the incidence, time of onset, and risk factors for irAEs, particularly ...
G. Kichenadasse +5 more
semanticscholar +1 more source
Treatment-related adverse events occurring in ≥1% of the total population (SS).
Treatment-related adverse events occurring in ≥1% of the total population (SS).
Lionel Noah (6095636) +7 more
core +1 more source
Number of Subjects with Related Treatment-Emergent Adverse Events by System Organ Class and Preferred Term.
Matthew Duchars (8713179) +12 more
core +1 more source
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga +3 more
wiley +1 more source
Objectives: Liposomal amphotericin B is a broad-spectrum antifungal treatment used for life-threatening infections, but it commonly induces infusion-related adverse events that may prevent treatment completion.
Iouri Banakh +2 more
doaj +1 more source
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation [PDF]
Abstract Objective To examine the impact of schizophrenia, its treatment and treatment-related adverse events related to antipsychotics, on quality of life from the perspective of schizophrenia patients and laypersons.
Reaney Matthew +6 more
openaire +3 more sources
Treatment reactions and adverse events possibly related to the treatment.
Treatment reactions and adverse events possibly related to the treatment.
Guoyu Zhou (3167277) +13 more
core +1 more source
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine +21 more
wiley +1 more source
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak +9 more
wiley +1 more source
Immunotherapy with CTLA-4 inhibitors and PD1 checkpoint inhibitors has initiated a breakthrough in the treatment and prognosis of patients with metastatic melanoma. The survival of these patients has increased from the expected survival time of less than
Mesti Tanja +3 more
doaj +1 more source

